AstraZeneca Finds No Evidence Of Increased Blood Clot Risk F
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
AstraZeneca said a review of safety data of people vaccinated with its Covid-19 vaccine has shown no evidence of an increased risk of blood clots. Health authorities in some countries suspended the use of its vaccine over clotting issues.

A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with Covid-19 vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country, the company said.

Authorities in Ireland, Denmark, Norway, Iceland, and the Netherlands have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating death from coagulation disorders. European medicines agency has said there is no indication that the events were caused by the vaccination, a view that was echoed by the World Health Organisation.

The drugmaker said, 15 events of deep vein thrombosis and 22 events of pulmonary embolism have been reported so far, which is similar across other licensed Covid-19 vaccines. The company said additional testing has and is being conducted by the company and the European health authorities and none of the re-tests have shown cause for concern.

Source:
https://health.economictimes.indiatimes.com/news/pharma/astrazeneca-finds-no-evidence-of-increased-blood-clot-risk-from-vaccine/81512504
Dr. T●●●●z H●●●●●●i and 6 others like this3 shares
Like
Comment
Share